Found 311 matching trials
Mogamulizumab and Pembrolizumab in Treating Patients With Relapsed or Refractory Diffuse Large B Cell Lymphoma PHASE1 This phase I/II trial studies the best dose and side effects of mogamulizum...
Show More Location
University of California Davis Comprehensive Cancer Center
Learn More & Join Trial
Erlotinib Hydrochloride With or Without Bevacizumab in Treating Patients With Stage IV Non-small Cell Lung Cancer With Epidermal Growth Factor Receptor Mutations PHASE2 This randomized phase II trial studies how well erlotinib hydrochloride (Ta...
Show More Location
UC San Diego Moores Cancer Center
Learn More & Join Trial
Ensartinib, Carboplatin, Pemetrexed and Bevacizumab for the Treatment of Stage IIIC or IV or Recurrent ALK-Positive Non-small Cell Lung Cancer PHASE1 This phase Ib trial finds the best dose and side effects of ensartinib and ...
Show More Status
Active Not Recruiting
Location
M D Anderson Cancer Center
Learn More & Join Trial
Tremelimumab and Durvalumab in Combination or Alone in Treating Patients With Recurrent Malignant Glioma PHASE2 The main purpose of this trial is to investigate the effects of a new class...
Show More Location
Northwestern University
Learn More & Join Trial
The Impact of Selected Factors on the Cardiovascular System in Chronic Kidney Disease N/A Chronic kidney disease (CKD), is characterized by accelerated development o...
Show More Location
Poznan University of Medical Sciences
Learn More & Join Trial
Olaparib and Durvalumab in Treating Participants With Metastatic Triple Negative Breast Cancer PHASE1 This pilot phase I trial studies whether it is feasible to conduct a detail...
Show More Location
OHSU Knight Cancer Institute
Learn More & Join Trial
Atezolizumab and Varlilumab in Combination With Radiation Therapy for NSCLC PHASE1 This phase I trial studies the side effects of atezolizumab, varlilumab, an...
Show More Location
Rutgers Cancer Institute of New Jersey
Learn More & Join Trial
Carboplatin and Paclitaxel or Oxaliplatin and Capecitabine With or Without Bevacizumab as First-Line Therapy in Treating Patients With Newly Diagnosed Stage II-IV or Recurrent Stage I Epithelial Ovarian or Fallopian Tube Cancer PHASE3 This randomized phase III trial studies carboplatin given together with pac...
Show More Status
Active Not Recruiting
Location
University of Alabama at Birmingham Cancer Center
Learn More & Join Trial
Bevacizumab and Anetumab Ravtansine or Paclitaxel in Treating Patients With Refractory Ovarian, Fallopian Tube, or Primary Peritoneal Cancer PHASE2 This phase II trial studies the side effects of bevacizumab and anetumab ra...
Show More Status
Active Not Recruiting
Location
UC Irvine Health/Chao Family Comprehensive Cancer Center
Learn More & Join Trial
Infliximab or Vedolizumab in Treating Immune Checkpoint Inhibitor-Related Colitis in Patients With Genitourinary Cancer or Melanoma PHASE1 This phase I/II trial studies the side effects of infliximab and vedolizuma...
Show More Status
Active Not Recruiting
Location
M D Anderson Cancer Center
Learn More & Join Trial